Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,641 | -12,294 | -39,445 | -27,330 | -19,923 |
| Depreciation Amortization | 123 | 28 | 243 | 177 | 111 |
| Accounts receivable | 595 | 959 | 998 | -1,173 | 1,091 |
| Accounts payable and accrued liabilities | 454 | -1,309 | -3,829 | -4,224 | -4,887 |
| Other Working Capital | 1,500 | -2,209 | -4,896 | -7,556 | -4,890 |
| Other Operating Activity | 3,532 | 2,685 | 9,128 | 9,848 | 6,840 |
| Operating Cash Flow | $-20,437 | $-12,140 | $-37,801 | $-30,258 | $-21,658 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -42,000 | -46,000 | N/A | N/A | N/A |
| PPE Investments | -54 | -19 | -427 | -308 | -206 |
| Investing Cash Flow | $-42,054 | $-46,019 | $-427 | $-308 | $-206 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 101 | 0 | 75,795 | 75,702 | 75,508 |
| Financing Cash Flow | $101 | $0 | $75,795 | $75,702 | $75,508 |
| Beginning Cash Position | 112,921 | 112,921 | 75,354 | 75,354 | 75,354 |
| End Cash Position | 50,531 | 54,762 | 112,921 | 120,490 | 128,998 |
| Net Cash Flow | $-62,390 | $-58,159 | $37,567 | $45,136 | $53,644 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,437 | -12,140 | -37,801 | -30,258 | -21,658 |
| Capital Expenditure | -54 | -19 | -427 | -308 | -206 |
| Free Cash Flow | -20,491 | -12,159 | -38,228 | -30,566 | -21,864 |